The Benchmark Company Achieves Significant Milestone of 20 Senior Analysts and Will Expand Coverage to Over 350 Companies
November 09, 2021 08:30 ET
|
The Benchmark Company
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused sales, trading & investment banking firm announced today a significant expansion of its equity...
The Benchmark Company Announces Upcoming Discovery One on One Virtual Investor Conference
November 11, 2020 10:00 ET
|
The Benchmark Company
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Discovery One on One Virtual Investor Conference on Wednesday, November 18th, 2020. The...
The Benchmark Company Announces Upcoming Technology One on One Virtual Investor Conference
November 05, 2020 10:21 ET
|
The Benchmark Company
NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual One on One Technology Investor Conference on Thursday, November 12th, 2020. The...
The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1x1 Investor Conference
June 11, 2020 16:34 ET
|
The Benchmark Company
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual 1x1 “Healthcare House Call” Investor Conference June 15-16th. The conference features...
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
May 28, 2020 10:02 ET
|
The Benchmark Company
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...
The Benchmark Company Announces Closing of $8 Million Registered Direct Offering for Cinedigm Corp.
May 26, 2020 18:37 ET
|
The Benchmark Company
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on May 22nd of a Registered Direct Offering of 10,666,666 shares of common stock of Cinedigm Corp. (NASDAQ:...
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
March 17, 2020 12:29 ET
|
The Benchmark Company
NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 7,500,000 shares of...
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
February 26, 2020 09:00 ET
|
The Benchmark Company, Llc
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
February 13, 2020 15:51 ET
|
The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...
The Benchmark Company Adds Kevin Sterling to Industrial Research Team
February 12, 2020 13:49 ET
|
The Benchmark Company, Llc
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the addition of Kevin Sterling to its rapidly growing equity research team. Kevin will cover the...